We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
If you're advertising or marketing, including direct marketing, you must be accurate and honest and follow the advertising codes of practice
All marketing and advertising must be: an accurate description of the…
Advertising to consumers The Consumer Protection from Unfair Trading…
There are 2 advertising codes of practice that describe how businesses…
You must describe your product accurately. This means if you make a claim…
You must check if customers want to be contacted by fax, phone, post or…
Guidance on conditional marketing authorisations, exceptional circumstances marketing authorisations and national scientific advice.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Guidance for holders of marketing authorisations (MAs) approved in Northern Ireland (NI) who want to bring a product to market in Great Britain (GB).
Steps to help grow your business - finding finance, mentors, increasing sales and developing products and services
Guidance for the pharmaceutical industry on how to apply for an authorisation to place a veterinary medicine on the UK market or part of, or to expire one.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
A speech by Sarah Cardell, the Competition and Markets Authority (CMA) Chief Executive, delivered at the techUK Tech Policy Conference 2025.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).